1. Antiplatelet versus oral anticoagulant therapy as antithrombotic prophylaxis after mitral valve repair 
Domenico Paparella, MD, Michele Di Mauro, MD, Keren Bitton Worms, MD, Gil Bolotin, MD, Claudio Russo, MD, Salvatore Trunfio, MD, Roberto Scrofani, MD, Carlo Antona, MD, Guglielmo Actis Dato, MD, Riccardo Casabona, MD, Andrea Colli, MD, Gino Gerosa, MD, Attilio Renzulli, MD, Filiberto Serraino, MD, Giuseppe Scrascia, MD, PhD, Salvatore Zaccaria, MD, Michele De Bonis, MD, Maurizio Taramasso, MD, Luis Delgado, MD, Francesco Tritto, MD, Joseph Marmo, MD, Alessandro Parolari, MD, Veronika Myaseodova, MD, Emmanuel Villa, MD, Giovanni Troise, MD, Francesco Nicolini, MD, Tiziano Gherli, MD, Richard Whitlock, MD, PhD, Manuela Conte, MD, Fabio Barili, MD, Sandro Gelsomino, MD, Roberto Lorusso, MD, PhD, Edoardo Sciatti, MD, Daniele Marinelli, MD, Gabriele Di Giammarco, MD, Antonio Maria Calafiore, MD, Azmat Sheikh, MD, Juan Jaime Alfonso, RA, Mattia Glauber, MD, Antonio Miceli, MD Crescenzia Rotunno, Ziv Beckerman, Luigi Martinelli, MD, Marco Lanfranconi, Davide Foresti, Egidio Varone, MD, Giuseppe Punta, MD, Ottavio Alfieri, MD, Elisabetta Lapenna, MD, Gennaro Ismeno, MD, Achille Pulcino, MD, Francesco Alamanni, MD, Margherita Dalla Tomba, MD, Giuseppe Coletti, MD, Enrico Vizzardi, MD, Antonio Lio, MD, Marco Solinas, MD, Massimiliano Foschi, MD Domenico Paparella, MD, Michele Di Mauro, MD, Keren Bitton Worms, MD, Gil Bolotin, MD, Claudio Russo, MD, Salvatore Trunfio, MD, Roberto Scrofani, MD, Carlo Antona, MD, Guglielmo Actis Dato, MD, Riccardo Casabona, MD, Andrea Colli, MD, Gino Gerosa, MD, Attilio Renzulli, MD, Filiberto Serraino, MD, Giuseppe Scrascia, MD, PhD, Salvatore Zaccaria, MD, Michele De Bonis, MD, Maurizio Taramasso, MD, Luis Delgado, MD, Francesco Tritto, MD, Joseph Marmo, MD, Alessandro Parolari, MD, Veronika Myaseodova, MD, Emmanuel Villa, MD, Giovanni Troise, MD, Francesco Nicolini, MD, Tiziano Gherli, MD, Richard Whitlock, MD, PhD, Manuela Conte, MD, Fabio Barili, MD, Sandro Gelsomino, MD, Roberto Lorusso, MD, PhD, Edoardo Sciatti, MD, Daniele Marinelli, MD, Gabriele Di Giammarco, MD, Antonio Maria Calafiore, MD, Azmat Sheikh, MD, Juan Jaime Alfonso, RA, Mattia Glauber, MD, Antonio Miceli, MD Crescenzia Rotunno, Ziv Beckerman, Luigi Martinelli, MD, Marco Lanfranconi, Davide Foresti, Egidio Varone, MD, Giuseppe Punta, MD, Ottavio Alfieri, MD, Elisabetta Lapenna, MD, Gennaro Ismeno, MD, Achille Pulcino, MD, Francesco Alamanni, MD, Margherita Dalla Tomba, MD, Giuseppe Coletti, MD, Enrico Vizzardi, MD, Antonio Lio, MD, Marco Solinas, MD, Massimiliano Foschi, MD 
The Journal of Thoracic and Cardiovascular Surgery 
Volume 151, Issue 5, Pages e1 (May 2016)
DOI: /j.jtcvs
Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

2. Figure 1 Consort diagram of the study.
The Journal of Thoracic and Cardiovascular Surgery  , e1DOI: ( /j.jtcvs )
Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

3. Figure 2
Main 6-month events in vitamin K antagonist (green columns) and antiplatelet therapy (red columns) in matched cohorts. *P < .05.
The Journal of Thoracic and Cardiovascular Surgery  , e1DOI: ( /j.jtcvs )
Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

4. Main 6-months events in patients receiving vitamin K antagonists (green) and antiplatelet therapy (red) in matched cohorts.
The Journal of Thoracic and Cardiovascular Surgery  , e1DOI: ( /j.jtcvs )
Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions